Dermatology Collaboration and Licensing Deals 2016-2026

Description

The definitive benchmark for dermatology dealmaking

Dermatology partnering spans a diverse range of indications, modalities, and commercial strategies, with deal structures shaped by both clinical innovation and lifecycle management considerations.

This report provides a comprehensive and structured analysis of 500+ dermatology collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how dermatology deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a diverse and commercially nuanced therapeutic landscape
Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within dermatology partnerships, particularly where lifecycle management and commercial positioning play a significant role.
Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data
What's included
500+ dermatology collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for dermatology dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how dermatology partnerships are structured, negotiated, and valued.

Product Code: CP2216

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in dermatology dealmaking

2.1. Introduction
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication

Chapter 3 - Financial deal terms for dermatology partnering

3.1. Introduction
3.2. Disclosed financials terms for dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates

Chapter 4 - Leading dermatology deals and dealmakers

4.1. Introduction
4.2. Most active in dermatology partnering
4.3. List of most active dealmakers in dermatology
4.4. Top dermatology deals by value

Chapter 5 - Dermatology contract document directory

5.1. Introduction
5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by dermatology therapeutic target
Deal directory
Deal directory - Dermatology deals by company A-Z
Deal directory - Dermatology deals by technology type
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Dermatology partnering since 2016
Figure 2: Dermatology partnering by deal type since 2016
Figure 3: Dermatology partnering by industry sector since 2016
Figure 4: Dermatology partnering by stage of development since 2016
Figure 5: Dermatology partnering by technology type since 2016
Figure 6: Dermatology partnering by indication since 2016
Figure 7: Dermatology deals with a headline value
Figure 8: Dermatology deals with upfront payment values
Figure 9: Dermatology deals with milestone payment
Figure 10: Dermatology deals with royalty rates
Figure 11: Active dermatology dealmaking activity since 2016
Figure 12: Top dermatology deals by value since 2016